文献速递产科母胎医学

和肽素与中段心房利钠肽前体在疑似或确诊子痫前期中的价值:与sFlt-1/PlGF比值比较

Copeptin and mid-regional pro-atrial natriuretic peptide in women with suspected or confirmed pre-eclampsia: comparison with sFlt-1/PlGF ratio.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

结果显示,在传统预测因素基础上加入sFlt-1/PlGF比值预测母体并发症的C-index为0.76,高于和肽素0.63和MR-proANP 0.67(传统因素单独0.60);预测胎儿/新生儿并发症时sFlt-1/PlGF比值C-index为0.83,亦高于和肽素0.79和MR-proANP 0.80(传统模型0.79)。和肽素和MR-proANP与蛋白尿独立相关。

要点

  • sFlt-1/PlGF比值预测子痫前期相关母体及胎儿/新生儿并发症的区分能力优于和肽素和MR-proANP。
  • 和肽素和MR-proANP是蛋白尿的独立决定因素,和肽素此效应独立于sFlt-1/PlGF比值。
  • sFlt-1/PlGF比值≥85者MR-proANP水平升高,和肽素水平无差异。

核心结论

  • 和肽素和MR-proANP在预测子痫前期相关并发症方面价值有限,不及sFlt-1/PlGF比值。
  • 和肽素和MR-proANP均与蛋白尿相关,其中和肽素此效应独立于sFlt-1/PlGF比值。

研究设计与样本

  • 共评估526例孕妇,入组时采血检测和肽素、MR-proANP、sFlt-1及PlGF血清水平。
  • 采用C-index比较各标志物单独或联合传统预测因素(孕周、产次、舒张压、蛋白尿)预测母体及胎儿/新生儿并发症的模型。

主要发现

  • 确诊子痫前期者血清和肽素和MR-proANP水平高于疑似子痫前期但无妊娠期高血压疾病者。
  • 预测母体并发症时,sFlt-1/PlGF比值联合传统因素的C-index为0.76,高于和肽素0.63和MR-proANP 0.67(传统因素单独0.60)。
  • 预测胎儿/新生儿并发症时,sFlt-1/PlGF比值联合传统因素的C-index为0.83,高于和肽素0.79和MR-proANP 0.80(传统因素单独0.79)。
  • 按sFlt-1/PlGF比值(≥85 vs <85)分层,和肽素水平无差异,而MR-proANP水平在比值≥85者中升高。
  • 多元回归分析显示和肽素和MR-proANP是蛋白尿的独立决定因素。

临床怎么用

  • 在疑似或确诊子痫前期孕妇中,sFlt-1/PlGF比值可作为预测母体及胎儿/新生儿并发症的优先生物标志物。
  • 和肽素和MR-proANP不宜替代sFlt-1/PlGF比值用于子痫前期相关并发症的风险预测。

局限性

  • 研究为回顾性分析,可能存在选择偏倚和信息偏倚。
  • 原文未报告和肽素和MR-proANP预测并发症的阈值、灵敏度及特异度等具体诊断效能指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Arginine vasopressin (AVP) and atrial natriuretic peptide (ANP) may contribute to the pathogenesis of pre-eclampsia (PE), but their role remains to be elucidated. Our aims were to evaluate the surrogates of AVP and ANP, C-terminal pro-AVP (copeptin) and mid-regional pro-ANP (MR-proANP), as biomarkers for the prediction of PE-related pregnancy complications and whether they are associated with angiogenic markers and/or clinical manifestations of PE. METHODS: This was a retrospective analysis of a prospective cohort study that enrolled pregnant women with suspected or confirmed PE, between December 2013 and April 2016. From each patient, a blood sample was obtained at study entry and serum levels of copeptin, MR-proANP, soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) were measured. We evaluated the ability of sFlt-1, PlGF, sFlt-1/PlGF ratio, copeptin and MR-proANP, assessed either alone or combined with traditional predictors (gestational age, parity, diastolic blood pressure and proteinuria), to predict maternal complications and fetal/neonatal complications. Models were compared using concordance statistic (C-index). RESULTS: A total of 526 women were evaluated in the study. Women with confirmed PE displayed elevated serum copeptin and MR-proANP levels in comparison to those with suspected PE but no hypertensive disease of pregnancy. When combined with traditional predictors, the sFlt-1/PlGF ratio displayed a higher C-index than copeptin and MR-proANP (0.76, 0.63 and 0.67, respectively, vs 0.60 for the traditional predictors alone) for the prediction of maternal complications. Similarly, for the prediction of fetal/neonatal complications, the sFlt-1/PlGF ratio displayed a higher C-index than copeptin and MR-proANP when added to the traditional model (0.83, 0.79 and 0.80, respectively, vs 0.79 for the traditional predictors alone). When subdividing women according to sFlt-1/PlGF ratio (≥ 85 vs < 85), no differences in copeptin levels were observed, while MR-proANP level was elevated in women with sFlt-1/PlGF ratio ≥ 85. Multiple regression analysis revealed that copeptin and MR-proANP were independent determinants of proteinuria. CONCLUSIONS: Copeptin and MR-proANP have limited value in predicting PE-related complications when compared with the sFlt-1/PlGF ratio. However, both copeptin and MR-proANP were associated with proteinuria, with copeptin exerting this effect independently of the sFlt-1/PlGF ratio. Copyright © 2020 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Neuman RI, van der Meer MMA, Saleh L, et al. Copeptin and mid-regional pro-atrial natriuretic peptide in women with suspected or confirmed pre-eclampsia: comparison with sFlt-1/PlGF ratio. Ultrasound Obstet Gynecol. 2020. PMID: 31975510. doi:10.1002/uog.21979

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。